WallStreetZenWallStreetZen

NASDAQ: GTHX
G1 Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GTHX past revenue growth

How has GTHX's revenue growth performed historically?
Company
60.84%
Industry
144.63%
Market
17.55%
GTHX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GTHX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GTHX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GTHX earnings and revenue history

Current Revenue
$82.5M
Current Earnings
-$48.0M
Current Profit Margin
-58.1%

GTHX Return on Equity

Current Company
-106%
Current Industry
-63.5%
Current Market
188%
GTHX's Return on Equity (-106%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GTHX announces earnings.

GTHX Return on Assets

Current Company
-34%
Current Industry
2.9%
GTHX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GTHX Return on Capital Employed

Current Company
-37.91%
Current Industry
19.5%
GTHX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GTHX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GTHX$82.51M-$34.30M-$47.97M+93.68%N/A
PSTX$64.70M-$109.04M-$123.43M+43.92%N/A
ATNM$81.00k-$45.63M-$46.45M-95.46%N/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
TELO$0.00-$11.43M-$13.07MN/AN/A
View Top Biotech Stocks

GTHX earnings dates

Next earnings date
Jun 13, 2024

G1 Therapeutics Earnings & Revenue FAQ

What were GTHX's earnings last quarter?

On Invalid Date, G1 Therapeutics (NASDAQ: GTHX) reported Q4 2023 earnings per share (EPS) of -$0.21, up 70.42% year over year. Total G1 Therapeutics earnings for the quarter were -$10.88 million. In the same quarter last year, G1 Therapeutics's earnings per share (EPS) was -$0.71.

If you're new to stock investing, here's how to buy G1 Therapeutics stock.

What was GTHX's earnings growth in the past year?

As of Q2 2024, G1 Therapeutics's earnings has grown year over year. G1 Therapeutics's earnings in the past year totalled -$47.97 million.

What is GTHX's earnings date?

G1 Therapeutics's earnings date is Invalid Date. Add GTHX to your watchlist to be reminded of GTHX's next earnings announcement.

What was GTHX's revenue last quarter?

On Invalid Date, G1 Therapeutics (NASDAQ: GTHX) reported Q4 2023 revenue of $14.87 million up 45.1% year over year. In the same quarter last year, G1 Therapeutics's revenue was $10.25 million.

What was GTHX's revenue growth in the past year?

As of Q2 2024, G1 Therapeutics's revenue has grown 60.84% year over year. This is 83.79 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. G1 Therapeutics's revenue in the past year totalled $82.51 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.